Share this post on:

Name :
LATH antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
LATH Rabbit Polyclonal antibody. Positive IHC detected in human breast cancer.

Tested applications :
ELISA, IHC

Species reactivity :
Human; other species not tested.

Alternative names :
RP11-49G10.8 antibody; RP11 49G10.8 antibody; LATH antibody; Latherin antibody; BASE antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of Peptide (Accession Number: AY180924). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: IHC: 1:20-1:200

Background :
LATH, also named as BASE, belongs to the BPI/LBP/Plunc superfamily and Plunc family. It is the major protein in sweat, has surfactant properties.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Collagen III Antibody Description
NF-κB p105/p50 Mouse mAb Protocol
NEDD8 Antibody: NEDD8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 9 kDa, targeting to NEDD8. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human, Rat.

Share this post on:

Author: Gardos- Channel